Annual Retained Earnings
-$1.62 B
-$139.67 M-9.45%
31 December 2023
Summary:
Intra-Cellular Therapies annual retained earnings is currently -$1.62 billion, with the most recent change of -$139.67 million (-9.45%) on 31 December 2023. During the last 3 years, it has fallen by -$680.06 million (-72.57%). ITCI annual retained earnings is now -5037781.62% below its all-time high of -$32.10 thousand, reached on 01 March 2013.ITCI Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Retained Earnings
-$1.67 B
-$26.32 M-1.60%
30 September 2024
Summary:
Intra-Cellular Therapies quarterly retained earnings is currently -$1.67 billion, with the most recent change of -$26.32 million (-1.60%) on 30 September 2024. Over the past year, it has dropped by -$86.37 million (-5.44%). ITCI quarterly retained earnings is now -3895134.88% below its all-time high of -$43.00 thousand, reached on 30 June 2013.ITCI Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ITCI Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -9.4% | -5.4% |
| 3 y3 years | -72.6% | -47.5% |
| 5 y5 years | -187.6% | -150.2% |
ITCI Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -72.6% | at low | -47.5% | at low |
| 5 y | 5 years | -187.6% | at low | -150.2% | at low |
| alltime | all time | <-9999.0% | at low | <-9999.0% | at low |
Intra-Cellular Therapies Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -$1.67 B(+1.6%) |
| June 2024 | - | -$1.65 B(+1.0%) |
| Mar 2024 | - | -$1.63 B(+0.9%) |
| Dec 2023 | -$1.62 B(+9.5%) | -$1.62 B(+1.8%) |
| Sept 2023 | - | -$1.59 B(+1.6%) |
| June 2023 | - | -$1.56 B(+2.8%) |
| Mar 2023 | - | -$1.52 B(+3.0%) |
| Dec 2022 | -$1.48 B(+21.0%) | -$1.48 B(+3.1%) |
| Sept 2022 | - | -$1.43 B(+3.9%) |
| June 2022 | - | -$1.38 B(+6.7%) |
| Mar 2022 | - | -$1.29 B(+5.9%) |
| Dec 2021 | -$1.22 B(+30.3%) | -$1.22 B(+7.6%) |
| Sept 2021 | - | -$1.14 B(+7.3%) |
| June 2021 | - | -$1.06 B(+6.9%) |
| Mar 2021 | - | -$989.84 M(+5.6%) |
| Dec 2020 | -$937.10 M(+32.0%) | -$937.10 M(+6.9%) |
| Sept 2020 | - | -$876.40 M(+6.7%) |
| June 2020 | - | -$821.22 M(+8.4%) |
| Mar 2020 | - | -$757.51 M(+6.7%) |
| Dec 2019 | -$710.10 M(+26.3%) | -$710.10 M(+6.1%) |
| Sept 2019 | - | -$669.52 M(+5.5%) |
| June 2019 | - | -$634.65 M(+6.3%) |
| Mar 2019 | - | -$597.21 M(+6.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | -$562.38 M(+38.1%) | -$562.38 M(+7.8%) |
| Sept 2018 | - | -$521.63 M(+8.6%) |
| June 2018 | - | -$480.11 M(+8.4%) |
| Mar 2018 | - | -$442.73 M(+8.7%) |
| Dec 2017 | -$407.25 M(+31.6%) | -$407.25 M(+8.0%) |
| Sept 2017 | - | -$377.04 M(+6.5%) |
| June 2017 | - | -$354.17 M(+5.3%) |
| Mar 2017 | - | -$336.41 M(+8.7%) |
| Dec 2016 | -$309.48 M(+60.3%) | -$309.48 M(+9.7%) |
| Sept 2016 | - | -$281.99 M(+12.0%) |
| June 2016 | - | -$251.72 M(+14.0%) |
| Mar 2016 | - | -$220.89 M(+14.4%) |
| Dec 2015 | -$193.05 M(+118.7%) | -$193.05 M(+17.6%) |
| Sept 2015 | - | -$164.21 M(+24.4%) |
| June 2015 | - | -$132.05 M(+19.5%) |
| Mar 2015 | - | -$110.54 M(+25.3%) |
| Dec 2014 | -$88.26 M(+53.3%) | -$88.26 M(+20.8%) |
| Sept 2014 | - | -$73.06 M(+9.6%) |
| June 2014 | - | -$66.64 M(+7.3%) |
| Mar 2014 | - | -$62.11 M(+7.9%) |
| Dec 2013 | -$57.56 M(>+9900.0%) | -$57.56 M(+16.2%) |
| Sept 2013 | - | -$49.52 M(>+9900.0%) |
| June 2013 | - | -$43.00 K |
| Mar 2013 | -$32.10 K | - |
FAQ
- What is Intra-Cellular Therapies annual retained earnings?
- What is the all time high annual retained earnings for Intra-Cellular Therapies?
- What is Intra-Cellular Therapies annual retained earnings year-on-year change?
- What is Intra-Cellular Therapies quarterly retained earnings?
- What is the all time high quarterly retained earnings for Intra-Cellular Therapies?
- What is Intra-Cellular Therapies quarterly retained earnings year-on-year change?
What is Intra-Cellular Therapies annual retained earnings?
The current annual retained earnings of ITCI is -$1.62 B
What is the all time high annual retained earnings for Intra-Cellular Therapies?
Intra-Cellular Therapies all-time high annual retained earnings is -$32.10 K
What is Intra-Cellular Therapies annual retained earnings year-on-year change?
Over the past year, ITCI annual retained earnings has changed by -$139.67 M (-9.45%)
What is Intra-Cellular Therapies quarterly retained earnings?
The current quarterly retained earnings of ITCI is -$1.67 B
What is the all time high quarterly retained earnings for Intra-Cellular Therapies?
Intra-Cellular Therapies all-time high quarterly retained earnings is -$43.00 K
What is Intra-Cellular Therapies quarterly retained earnings year-on-year change?
Over the past year, ITCI quarterly retained earnings has changed by -$86.37 M (-5.44%)